| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | Director | Common Stock | 55.3K | $162K | $2.93 | Jan 9, 2025 | Direct |
| Perspective Therapeutics, Inc. | Director | Common Stock | 26K | $100K | $3.85 | Dec 4, 2024 | By Revocable Trust |
| Perspective Therapeutics, Inc. | Director | Stock option (right to buy) | 50K | Mar 3, 2025 | Direct | ||
| PepGen Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 4, 2025 | Direct | ||
| PARDES BIOSCIENCES, INC. | Chief Financial Officer | Common Stock | 0 | $1.50 | Aug 31, 2023 | Direct | |
| PARDES BIOSCIENCES, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Aug 31, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PEPG | PepGen Inc. | Jun 4, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director |
| CATX | Perspective Therapeutics, Inc. | Mar 3, 2025 | 1 | $0 | 4 | Mar 5, 2025 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2025 | 1 | $0 | 4 | Jan 13, 2025 | Director |
| CATX | Perspective Therapeutics, Inc. | Dec 4, 2024 | 1 | $100K | 4 | Dec 6, 2024 | Director |
| CATX | Perspective Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| PEPG | PepGen Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2024 | 1 | $0 | 4 | Jan 11, 2024 | Director |
| CATX | Perspective Therapeutics, Inc. | Dec 12, 2023 | 1 | $0 | 4 | Dec 14, 2023 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Aug 31, 2023 | 5 | $0 | 4 | Aug 31, 2023 | Chief Financial Officer |
| PEPG | PepGen Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| CATX | Perspective Therapeutics, Inc. | Jun 2, 2023 | 2 | $0 | 4 | Jun 6, 2023 | Director |
| CATX | Perspective Therapeutics, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 2, 2023 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Chief Financial Officer |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Sep 15, 2022 | 0 | $0 | 3 | Sep 16, 2022 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Sep 14, 2022 | 1 | $0 | 4 | Sep 16, 2022 | Chief Financial Officer |
| PEPG | PepGen Inc. | May 6, 2022 | 1 | $0 | 4 | May 10, 2022 | Director |
| PEPG | PepGen Inc. | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer |
| PRDS | PARDES BIOSCIENCES, INC. | Dec 23, 2021 | 0 | $0 | 3 | Dec 27, 2021 | Chief Financial Officer |